Last reviewed · How we verify
NCT06254989: ESAP-CS
Effectiveness of an Aerobic Exercise Program in Cancer Survivors.
NA trial testing Aerobic Exercise in Aerobic Exercise in 15 participants. Status unknown.
28 February 2025
Quick facts
| Lead sponsor | Holy Name Medical Center, Inc. |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 15 |
| Start date | 12 February 2024 |
| Primary completion | 28 February 2025 |
| Estimated completion | 30 June 2025 |
Drugs / interventions tested
- Aerobic Exercise — full drug profile →
Conditions studied
- Aerobic Exercise — all drugs for Aerobic Exercise →
Sponsor
Holy Name Medical Center, Inc.
Who can join
18 and older, any sex, with Aerobic Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective study of cancer survivor patients enrolling in a pilot aerobic exercise program. The total enrollment will be fifteen patients. The study timeline includes a screening period of 4 weeks, baseline period of 2 weeks, and active study intervention for 12 weeks. Study enrollment will continue until all 15 subjects are enrolled or up to 12 months, whichever comes first.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06254989
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Aerobic Exercise
Trials testing the same drug.
- NCT07517224 — Assessing the Effect of an Aerobic Exercise Program on Vascular Function in Women With Non-Metastatic Breast Cancer · NA · not yet recruiting
- NCT07444333 — Cardiac Output and Fatigue in Friedreich's Ataxia · NA · not yet recruiting
- NCT07182006 — Exercise as Medicine for Pediatric Chronic Pain · NA · not yet recruiting
- NCT07404319 — Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant · NA · not yet recruiting
- NCT07302204 — Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis · NA · recruiting
Other recruiting trials for Aerobic Exercise
Currently open trials in the same condition.
- NCT07469540 — Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arth · NA · recruiting
- NCT07216495 — Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC · NA · recruiting
- NCT07002125 — Whole Body Vibration Therapy in Individuals With Type 2 Diabetes · NA · recruiting
- NCT07070791 — Combined Upper Extremity Resistance and Aerobic Exercise Training in Patients With Breast Cancer · NA · recruiting
- NCT07070778 — Arterial Stiffness in Individuals With Breast Cancer · NA · recruiting
Other Holy Name Medical Center, Inc. trials
Trials by the same sponsor.
- NCT03604653 — Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers · completed
- NCT03614910 — Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System · completed
- NCT03424733 — Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06254989 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Holy Name Medical Center, Inc.
- Last refreshed: 12 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06254989.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing